AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Dudley, ME Wunderlich, J Nishimura, MI Yu, D Yang, JC Topalian, SL Schwartzentruber, DJ Hwu, P Marincola, FM Sherry, R Leitman, SF Rosenberg, SA
Citation: Me. Dudley et al., Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma, J IMMUNOTH, 24(4), 2001, pp. 363-373

Authors: Orentas, RJ Roskopf, SJ Nolan, GP Nishimura, MI
Citation: Rj. Orentas et al., Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide, CLIN IMMUNO, 98(2), 2001, pp. 220-228

Authors: McKee, MD Clay, TM Diamond, RA Rosenberg, SA Nishimura, MI
Citation: Md. Mckee et al., Quantitation of T-cell receptor frequencies by competitive polymerase chain reaction: Dynamics of T-cell clonotype frequencies in an expanding tumor-infiltrating lymphocyte culture, J IMMUNOTH, 23(4), 2000, pp. 419-429

Authors: Ladanyi, A Nishimura, MI Rosenberg, SA Yang, JC
Citation: A. Ladanyi et al., Tumorigenicity and immunogenicity of murine tumor cells expressing an MHC class II molecule with a covalently bound antigenic peptide, J IMMUNOTH, 23(1), 2000, pp. 36-47

Authors: Dudley, ME Nishimura, MI Holt, AKC Rosenberg, SA
Citation: Me. Dudley et al., Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads toa functionally heterogeneous CTL response, J IMMUNOTH, 22(4), 1999, pp. 288-298

Authors: McKee, MD Clay, TM Rosenberg, SA Nishimura, MI
Citation: Md. Mckee et al., Quantitation of T-cell receptor frequencies by competitive PCR: Generationand evaluation of novel TCR subfamily and clone specific competitors, J IMMUNOTH, 22(2), 1999, pp. 93-102

Authors: Housseau, F Bright, RK Simonis, T Nishimura, MI Topalian, SL
Citation: F. Housseau et al., Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+T cells, J IMMUNOL, 163(11), 1999, pp. 6330-6337

Authors: Clay, TM Custer, MC Sachs, J Hwu, P Rosenberg, SA Nishimura, MI
Citation: Tm. Clay et al., Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity, J IMMUNOL, 163(1), 1999, pp. 507-513

Authors: Clay, TM Custer, MC McKee, MD Parkhurst, M Robbins, PF Kerstann, K Wunderlich, J Rosenberg, SA Nishimura, MI
Citation: Tm. Clay et al., Changes in the fine specificity of gp100((209-217))-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue, J IMMUNOL, 162(3), 1999, pp. 1749-1755

Authors: Pieper, R Christian, RE Gonzales, MI Nishimura, MI Gupta, G Settlage, RE Shabanowitz, J Rosenberg, SA Hunt, DF Topalian, SL
Citation: R. Pieper et al., Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells, J EXP MED, 189(5), 1999, pp. 757-765

Authors: Nishimura, MI Avichezer, D Custer, MC Lee, CS Chen, C Parkhurst, MR Diamond, RA Robbins, PF Schwartzentruber, DJ Rosenberg, SA
Citation: Mi. Nishimura et al., MHC class I-restricted recognition of a melanoma antigen by a human CD4(+)tumor infiltrating lymphocyte, CANCER RES, 59(24), 1999, pp. 6230-6238
Risultati: 1-11 |